Policy and Practice - Medika Life

Patents are essential in the pharmaceutical industry to ensure commercial viability and financial returns but how do they effect public access to vaccines in a pandemic?

Your Best Defense Against Denials: DOCUMENTATION

Dr. Hesham A. Hassaballa - October 24, 2022

We have been traveling on a journey through the very frustrating, annoying, and obnoxious world of health insurance company denials. Whether it be a...

Covid is Never Going to Be Over. We Need to Plan Accordingly

Robert Turner, Founding Editor - January 25, 2021

Is SARS-CoV-2 nothing more than aggressive Influenza, a new breed of Flu. It looks that way and it may be here to stay. We need to deal with that.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

India: The Growing Focal Point for Health Innovation

GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens

Medical Innovation Still Matters—Even When the System Makes It Hard

Who Will Direct Patient Care: Physicians or Technocrats?

LATEST

TRENDING

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

We Know the Health Ecosystem is Fragmented, Resulting in Rising Costs and Poorer Patient Outcomes, But What Are We Doing About It?

Another AFLDS Quack, Meet Dr. Peterson Pierre

Texas Senator Attempts to Stop All Required Vaccinations in Proposed Bill

Exposing the Dark World of Predatory Health

The Amazon and One Medical Combo May Not Disrupt the Health System Now – They Will Champion its Transformation

Health Possibilities We Can’t Afford to Block

America’s Frontline Doctors Want to Become the New Republic’s NIH

Galen Growth + ViVE 2024 Champion Digital Health Innovation as a Salve for an Ailing US Health Ecosystem

EDITORS CHOICE

ViVE Was an Out-of-the-Box Hit Among the Digital Health and Health Innovation Tribe

Vaccine Patents Come with Ethical Dilemmas Bringing Life or Death

Your Best Defense Against Denials: DOCUMENTATION

Covid is Never Going to Be Over. We Need to Plan Accordingly

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories